Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 1551: All of the following are used for treatment of H. pylori, except:

A. Metronidazole
B. Amoxicillin
C. Clarithromycin
D. Gentamicin (Correct Answer)

Explanation: ***Gentamicin*** - **Gentamicin** is an **aminoglycoside antibiotic** primarily used for severe Gram-negative bacterial infections and is **not effective** against *H. pylori*. - Its mechanism of action and **toxicity profile** (ototoxicity, nephrotoxicity) make it unsuitable for typical *H. pylori* eradication regimens. *Clarithromycin* - **Clarithromycin** is a **macrolide antibiotic** frequently used in **triple therapy regimens** for *H. pylori* eradication. - It works by **inhibiting bacterial protein synthesis**, significantly contributing to the eradication of the bacteria. *Metronidazole* - **Metronidazole** is an **antibiotic** and **antiprotozoal agent** commonly included in *H. pylori* **quadruple therapy** or when penicillin allergies are present. - It acts by forming **cytotoxic compounds** that disrupt bacterial DNA, making it effective against anaerobic and microaerophilic bacteria like *H. pylori*. *Amoxicillin* - **Amoxicillin** is a **beta-lactam antibiotic** that is a cornerstone of many *H. pylori* **eradication regimens**, particularly in standard triple therapy. - It works by **inhibiting bacterial cell wall synthesis**, leading to bacterial lysis.

Question 1552: What is the best skin disinfectant for central line insertion?

A. Alcohol
B. Cetrimide
C. Chlorhexidine (Correct Answer)
D. Povidone iodine

Explanation: ***Chlorhexidine*** - **Chlorhexidine (particularly >0.5% chlorhexidine in alcohol-based solution, such as 2% chlorhexidine in 70% isopropyl alcohol)** is the preferred antiseptic for central line insertion per **CDC guidelines**. - It provides **rapid onset of action**, persistent antimicrobial activity (lasting several hours), and broad-spectrum efficacy against gram-positive and gram-negative bacteria, fungi, and some viruses. - Superior to povidone-iodine in reducing catheter-related bloodstream infections (CRBSIs) in multiple studies. - Its mechanism involves disrupting bacterial cell membranes and coagulating intracellular contents, leading to sustained antimicrobial activity on the skin. *Povidone iodine* - **Povidone iodine** has a slower onset of action and is inactivated by organic matter (blood, serum), making it less effective for immediate, sustained disinfection compared to chlorhexidine. - While it has broad-spectrum activity, its residual effect is limited once it dries on the skin. - Studies show higher rates of catheter-related infections compared to chlorhexidine-based antiseptics. *Alcohol* - **Alcohol** (e.g., isopropyl alcohol or ethanol) provides good immediate microbial kill but lacks persistent activity, meaning its effect is short-lived as it evaporates quickly from the skin. - It works by denaturing proteins and dissolving lipids, but its rapid evaporation makes it insufficient as a sole agent for central line insertion. - Often used as a component in combination with chlorhexidine for optimal efficacy. *Cetrimide* - **Cetrimide** is a quaternary ammonium compound with antiseptic properties, but it has a narrower spectrum of activity and is less potent than chlorhexidine for surgical site preparation. - It is often used in combination with other agents or for general skin cleansing rather than for critical procedures like central line insertion. - Not recommended as a primary antiseptic for central venous catheter insertion.

Question 1553: Which antibiotic is primarily associated with Red man syndrome?

A. Polymyxin B
B. Rifampicin
C. Vancomycin (Correct Answer)
D. Teicoplanin

Explanation: **Vancomycin** - **Red man syndrome** is a well-known **infusion-related reaction** primarily associated with vancomycin. - It occurs due to the **rapid infusion** of vancomycin, leading to non-immunologic **mast cell degranulation** and histamine release. - Characterized by flushing, pruritus, and erythema of the upper body and face. - **Prevention:** Slow infusion rate (over 60 minutes or longer) and/or premedication with antihistamines. *Polymyxin B* - Polymyxin B is associated with **nephrotoxicity** and **neurotoxicity**, not typically with Red man syndrome. - It can cause **histamine release** leading to flushing and itching, but this is less common and less severe than with vancomycin. *Rifampicin* - Rifampicin is primarily known for causing **orange-red discoloration** of bodily fluids (e.g., urine, tears, sweat) and can cause **hepatotoxicity**, but not Red man syndrome. - It works by inhibiting bacterial **RNA synthesis** and is used to treat tuberculosis and other mycobacterial infections. *Teicoplanin* - Teicoplanin is a **glycopeptide antibiotic** similar to vancomycin, but it has a **significantly lower incidence** of Red man syndrome. - While it can cause some **infusion-related reactions**, they are generally milder and less frequent compared to vancomycin.

Question 1554: What is the primary purpose of administering a multidrug regimen for tuberculosis (TB) treatment?

A. To prevent the development of drug resistance (Correct Answer)
B. To provide broad-spectrum coverage
C. To minimize side effects
D. To ensure treatment adherence

Explanation: ***To prevent the development of drug resistance*** - Using multiple drugs simultaneously targets different bacterial pathways, reducing the likelihood of *Mycobacterium tuberculosis* evolving resistance to any single drug [1] - This strategy ensures that even if a few bacteria are naturally resistant to one drug, other drugs in the regimen will eliminate them [1] - This is the fundamental principle behind multidrug TB therapy as per WHO guidelines *To provide broad-spectrum coverage* - TB treatment uses multiple drugs specifically against *Mycobacterium tuberculosis*, not for broad-spectrum coverage [2] - These regimens are tailored to the known characteristics of TB bacteria, not to cover a wide range of pathogens [2] - The drugs used (rifampicin, isoniazid, pyrazinamide, ethambutol) are relatively specific for mycobacteria [2] *To minimize side effects* - Administering multiple anti-TB drugs actually increases the risk of cumulative side effects due to drug interactions and individual toxicities [3] - Each drug has its own toxicity profile (hepatotoxicity, optic neuritis, hyperuricemia) [3] - While side effects are monitored, minimizing them is not the primary reason for multidrug approach *To ensure treatment adherence* - Treatment adherence refers to the patient's consistent use of prescribed medications, not the number of drugs - A complex multidrug regimen can actually make adherence more challenging - Directly Observed Therapy (DOT) is often needed to improve adherence with multidrug regimens

Question 1555: Which sulphonamide has the longest acting duration?

A. Sulfadiazine
B. Sulphadoxine (Correct Answer)
C. Sulfamethoxazole
D. Sulfamethiazole

Explanation: ***Sulphadoxine*** - **Sulphadoxine** is known for its **exceptionally long elimination half-life**, which is due to its high plasma protein binding and slow renal excretion. - This property allows for **once-weekly dosing**, making it one of the longest-acting sulfonamides, often used in combinations for malaria prophylaxis or treatment. *Sulfadiazine* - **Sulfadiazine** has an intermediate half-life, typically requiring **multiple daily doses**. - It is commonly used for infections like **toxoplasmosis** and **nocardiosis**. *Sulfamethoxazole* - **Sulfamethoxazole** has an intermediate half-life, usually requiring **twice-daily administration**. - It is most famously co-formulated with **trimethoprim** (as co-trimoxazole) for a broad range of bacterial infections. *Sulfamethiazole* - **Sulfamethiazole** is a **short-acting sulfanilamide derivative** with a rapid elimination, meaning it would require frequent dosing. - It is not commonly used systemically due to its short duration of action.

Question 1556: What is the mechanism of action of quinolones?

A. Inhibit tetrahydrofolate reductase
B. Inhibit DNA gyrase (Correct Answer)
C. Bind to 30S ribosomal subunit
D. Bind to bacterial cell membrane

Explanation: ***Inhibit DNA gyrase*** - Quinolones, particularly **fluoroquinolones**, exert their bactericidal effect by targeting **bacterial DNA gyrase (topoisomerase II)** and **topoisomerase IV**. - This inhibition prevents the uncoiling and replication of bacterial DNA, leading to cell death. *Bind to 30S ribosomal subunit* - This mechanism is characteristic of **aminoglycosides** and **tetracyclines**, which disrupt bacterial protein synthesis. - Quinolones do not interfere with ribosomal function but rather with **DNA replication**. *Bind to bacterial cell membrane* - This is the mechanism of action for **polymyxins** and **daptomycin**, which disrupt the integrity of the bacterial cell membrane. - Quinolones specifically target **intracellular enzymes** involved in DNA handling. *Inhibit tetrahydrofolate reductase* - This enzyme name in the option is technically imprecise; **trimethoprim** actually inhibits **dihydrofolate reductase**, which is part of the **sulfonamide-trimethoprim (Bactrim)** combination. - This pathway is involved in **folic acid synthesis**, crucial for bacterial DNA and RNA production, a mechanism distinct from quinolones.

Question 1557: As per RNTCP guidelines, Multi drug resistance (MDR) TB is defined as resistance to:

A. Rifampicin
B. Rifampicin, isoniazid and ethambutol
C. None of the above
D. Rifampicin and isoniazid (Correct Answer)

Explanation: ***Rifampicin and isoniazid*** - According to **RNTCP guidelines** (now NTEP), **MDR-TB** is specifically defined as tuberculosis that is resistant to at least both **rifampicin** and **isoniazid**. - These two drugs are the **most potent first-line anti-TB medications**, and resistance to both significantly complicates treatment. *Rifampicin* - While resistance to **rifampicin alone** is a serious concern, it is classified as **rifampicin-resistant TB (RR-TB)**, not full **MDR-TB**. - **MDR-TB** requires resistance to at least two key first-line drugs. *Rifampicin, isoniazid and ethambutol* - Resistance to **rifampicin**, **isoniazid**, and **ethambutol** would be a form of **MDR-TB** (as it includes resistance to rifampicin and isoniazid), but it is a more extensive form of resistance. - The minimum definition of **MDR-TB** focuses on the two most crucial first-line drugs. *None of the above* - This option is incorrect because there is a specific definition for **MDR-TB** that aligns with one of the provided choices. - The guidelines clearly define **MDR-TB** based on resistance to specific drugs.

Question 1558: Sulphonamide injection causes decrease in folic acid by?

A. Inhibition through competition with substrate (Correct Answer)
B. Inhibition without competition
C. Inhibition through a different site
D. Inhibition that does not involve the active site

Explanation: ***Inhibition through competition with substrate***Sulphonamides are **structural analogs of p-aminobenzoic acid (PABA)**, a substrate crucial for dihydropteroate synthase [1, 2]. They competitively inhibit this enzyme, which synthesizes **dihydrofolic acid**, a precursor to **tetrahydrofolic acid (THF)**, thereby reducing folic acid production in bacteria [1, 2].*Inhibition without competition*This typically refers to **non-competitive inhibition**, where the inhibitor binds to an allosteric site and changes the enzyme's conformation, regardless of substrate concentration. Sulphonamides, however, specifically compete with PABA at the active site of **dihydropteroate synthase**.*Inhibition through a different site*This describes **allosteric inhibition** or non-competitive inhibition, where the inhibitor binds to a site other than the active site. Sulphonamides do not work through an allosteric mechanism; they directly interfere with the binding of PABA at the enzyme's active site.*Inhibition that does not involve the active site*This is another way to describe **non-competitive** or **allosteric inhibition**, where the inhibitor binds elsewhere on the enzyme, altering its function without directly blocking the active site. Sulphonamides' mechanism is distinct, as they closely resemble the natural substrate and directly compete for the active site of **dihydropteroate synthase**.

Question 1559: All are true about ciprofloxacin except?

A. More active at acidic pH (Correct Answer)
B. DNA gyrase inhibition
C. Contraindicated in pregnancy
D. Second generation fluoroquinolone

Explanation: ***More active at acidic pH*** - Fluoroquinolones, including ciprofloxacin, exhibit **reduced antibacterial activity in acidic environments**. Their efficacy is generally better at **neutral or alkaline pH**. - This is clinically relevant as fluoroquinolones may have **reduced effectiveness in acidic sites** like the stomach or acidic urine. - The optimal antibacterial activity occurs at physiological or slightly alkaline pH. *DNA gyrase inhibition* - Ciprofloxacin, like other fluoroquinolones, exerts its antibacterial effect by inhibiting **bacterial DNA gyrase (topoisomerase II)** and **topoisomerase IV**. - This inhibition prevents DNA replication and repair, leading to bacterial cell death. *Contraindicated in pregnancy* - Ciprofloxacin is generally **contraindicated in pregnancy** due to concerns about potential harm to the developing fetus, particularly effects on **cartilage development**. - However, it may be used in specific, life-threatening situations if the benefit outweighs the potential risk. *Second generation fluoroquinolone* - Ciprofloxacin is classified as a **second-generation fluoroquinolone**. - This class includes agents with improved activity against Gram-negative bacteria and some atypical organisms.

Question 1560: What is the primary reason for using a combination of four drugs in Anti-Koch's Treatment (AKT) for tuberculosis?

A. To decrease the risk of resistance due to mutation. (Correct Answer)
B. To decrease the risk of resistance due to conjugation.
C. To enhance overall treatment efficacy.
D. To simplify treatment.

Explanation: ***To decrease the risk of resistance due to mutation*** - **Tuberculosis bacteria** can spontaneously develop resistance to a single drug through **random genetic mutations**. - Using multiple drugs simultaneously significantly reduces the probability that a bacterium will spontaneously develop resistance to **all drugs** in the regimen. - This is the **primary rationale** for multi-drug therapy in TB, as emphasized by WHO guidelines. *To decrease the risk of resistance due to conjugation* - **Conjugation** is a mechanism of horizontal gene transfer in bacteria, primarily involving the transfer of plasmids. - While important for antibiotic resistance in some bacteria, it is **not the primary mechanism** of resistance development in *Mycobacterium tuberculosis*. - TB resistance develops mainly through **chromosomal mutations**, not plasmid transfer. *To enhance overall treatment efficacy* - While multi-drug regimens do enhance treatment efficacy by targeting different bacterial populations (actively dividing, slow-growing, dormant), this is a **consequence** of the multi-drug approach. - The **primary reason** for using four drugs specifically is to prevent the emergence of **drug-resistant mutants**. - Enhanced efficacy is achieved *because* resistance is prevented, making this a secondary benefit. *To simplify treatment* - A four-drug regimen actually makes treatment more **complex** due to multiple pills, potential drug interactions, and increased side effects. - The complexity is a necessary trade-off for **resistance prevention** and treatment success.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free